Cargando…
Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedrops
Rebamipide eyedrops are approved in Japan for the treatment of dry eye disease. Some patients with allergic conjunctival diseases also manifest dry eye. Earlier we reported that rebamipide suppressed polyI:C-induced inflammatory cytokines in human conjunctival epithelial cells. In the current study...
Autores principales: | Ueta, Mayumi, Shoji, Jun, Sotozono, Chie, Kinoshita, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334922/ https://www.ncbi.nlm.nih.gov/pubmed/25705372 http://dx.doi.org/10.1186/2045-7022-4-40 |
Ejemplares similares
-
Difference in the plasma level of miR‐628‐3p in atopic dermatitis patients with/without atopic keratoconjunctivitis
por: Ueta, Mayumi, et al.
Publicado: (2021) -
Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2017) -
Anti-inflammatory effect of rebamipide on the ocular surface
por: Ueta, Mayumi, et al.
Publicado: (2013) -
Long-Term Benefits of Tear Exchangeable Limbal-Rigid Contact Lens Wear Therapy in Stevens–Johnson Syndrome Cases
por: Yoshikawa, Yamato, et al.
Publicado: (2023) -
Salivary levels of IgE and ECP in patients with recurrent aphthous stomatitis
por: Farhad-Mollashahi, Leila, et al.
Publicado: (2020)